- Home
- IBP vs APLS Comparison
IBP vs APLS Comparison
Compare IBP & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBP
- APLS
- Stock Information
- Founded
- IBP 1977
- APLS 2009
- Country
- IBP United States
- APLS United States
- Employees
- IBP N/A
- APLS N/A
- Industry
- IBP Homebuilding
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- IBP Consumer Discretionary
- APLS Health Care
- Exchange
- IBP Nasdaq
- APLS Nasdaq
- Market Cap
- IBP 4.9B
- APLS 4.0B
- IPO Year
- IBP 2014
- APLS 2017
- Fundamental
- Price
- IBP $201.30
- APLS $30.13
- Analyst Decision
- IBP Buy
- APLS Buy
- Analyst Count
- IBP 11
- APLS 18
- Target Price
- IBP $247.00
- APLS $46.71
- AVG Volume (30 Days)
- IBP 288.1K
- APLS 2.1M
- Earning Date
- IBP 02-20-2025
- APLS 02-25-2025
- Dividend Yield
- IBP 0.52%
- APLS N/A
- EPS Growth
- IBP 2.96
- APLS N/A
- EPS
- IBP 9.00
- APLS N/A
- Revenue
- IBP $2,911,800,000.00
- APLS $715,216,000.00
- Revenue This Year
- IBP $7.39
- APLS $95.82
- Revenue Next Year
- IBP $4.09
- APLS $12.02
- P/E Ratio
- IBP $22.35
- APLS N/A
- Revenue Growth
- IBP 6.10
- APLS 162.10
- 52 Week Low
- IBP $169.02
- APLS $24.34
- 52 Week High
- IBP $281.04
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- IBP 61.39
- APLS 44.83
- Support Level
- IBP $193.08
- APLS $27.61
- Resistance Level
- IBP $204.15
- APLS $30.13
- Average True Range (ATR)
- IBP 6.00
- APLS 1.50
- MACD
- IBP 4.47
- APLS -0.35
- Stochastic Oscillator
- IBP 91.89
- APLS 33.82
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is generated from Installation segment.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.